Etiopathophysiology of disseminated intravascular coagulation

Journal of Association of Physicians of India

Volumn 51, Issue AUG, 2003, Pages 796-800

  Bakhshi, S ^a   Arya, L S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOLYSIS; GYNECOLOGIC DISEASE; HUMAN; INFECTION; INJURY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR DISEASE;

BLOOD COAGULATION; CYTOKINES; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRINOLYSIS; GENITAL DISEASES, FEMALE; HUMANS; INFECTION; RISK FACTORS; VASCULAR DISEASES; WOUNDS AND INJURIES;

EID: 1542679304     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (40)

1. Lasch HG, Heene DL, Huth K, Sandritter W. Pathophysiology, clinical manifestations, and therapy of consumptive coagulopathy. Am J Cardiol 1967;20:381-91.
2. Rodriguez-Erdmann F. Bleeding due to increased intravascular coagulation: hemorrhagic syndromes caused by concumption of blood-clotting factors (consumption coagulopathy). N Engl J Med 1965;273:1370-8.
3. Dubber AHC, McNicol GP, Douglas AS. Acquired hypofibrinogenemia: the "defibrination syndrome". A study of seven patients. Scott Med J 1967;12:138-51.
4. Mersky C, Johnson AJ, Kleiner GJ, Wohl H. The defibrination syndrome: clinical features and laboratory diagnosis. Br J Haematol 1967;13:528-49.
5. Bick RL. Disseminated intravascular coagulation: pathophysiological mechanisms and manifestations. Semin Thromb Hemostas 1998;24:3-18.
6. Fourrier F, Chopin C, Goudemand J, Hendryscx S, Caron C, Rime A, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992;101:816-23.
7. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-23.
8. Gregory SA, Morrissey JH, Edginton TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989;9:2752-55.
9. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987;79:124-30.
10. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989;320:1165-72.
11. Biemond BJ, Levi M, ten Cate H, Van der Poll T, Buller HR, Kack CE, et al. Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxemia in chimpanzees: effects of interventions in the cytkine and coagulation cascades. Clin Science 1995;88:587-94.
12. Friedman HM, Macarak EJ, MacGregor RR, Wolfe J, Kefalides NA. Virus infection of endothelial cells. J Infec Dis1981;143:266-73.
13. Fisher-Hoch SP. The haemostatic defect in viral haemmorhagic fevers. Br J Haematol 1983;55:565-71.
14. Ramanathan CS, Taylor EW. Coputational genomic analysis of haemorrhagic fever viruses. Viral selenoproteins as a potential factor in pathogenesis. Biological Trace Element Res 1997;56:93-106.
15. Gordon SG, Hasiba U, Cross BA, Poole MA, Falanga A. Cysteine proteinase procoagulant from amnion-chorion. Blood 1985;66:1261-5.
16. Weiner CP. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 1986;13:705-17.
17. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. N Eng J Med 1999;340:994-1004.
18. Edwards RL, Morgan DL, Rickles FR. Animal tumour procoagulants. Registry of the Subcommittee on Hemostasis and Malignancy of the Scientific and Stndardization Committee, International Soceity of Thrombosis and Hemostasis. Thromb Hemost 1990;63:133-8.
19. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992;11:237-42.
20. Baker WF. Clinical aspects of disseminated intravascular coagulation: a clinician's point of view. Semin Thromb Hemostas 1989;15:1-57.
21. Bick RL, Tse N. Hemostasis abnormalities associated with prosthetic devices and organ transplantation. Lab Med 1992;23:462-8.
22. Bouchama A, Hammami M, Haq A, Jackson J, Al-Seairy S. Evidence for endothelial cell activation/injury in heat stroke. Crit Care Med 1996;24:1173-8.
23. Gando S, Kameue T, Nanzaki Y. Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Thromb Res 1995;80:519-26.
24. Hoffman M, Cooper ST. Thrombin enhances monocyte secretion of tumour necrosis factor and interleukin-1 by two distinct mechanisms. Blood Cells, Molecules and Diseases 1995;21:156-67.
25. Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K. Plasma levels of soluble E-selectin in patients with disseminated intravascular coagulation. Am J Hematol 1997;54:219-24.
26. Muller-Beghaus G. Pathophysiologic and biochemical events in disseminated intravascular coagulation: dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemostas 1989;15:1815-29.
27. Bang NU, Chang M. Soluble fibrin complexes. Semin Thromb Hemostas 1974;1:91-128.
28. Bick RL. The clinical significance of fibrinogen degradation products. Semin Thromb Hemostas 1982;8:302-30.
29. Francis CW, Marder VJ. A molecular model of plasmin degradation of cross-linked fibrin. Semin Thromb Hemostas 1982;8:36-56.
30. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in post-trauma disseminated intravascular coagulation: relationship to multiple organ dysfunction. Critical Care Med 1995;23:1835-42.
31. Robson S, Shephard E, Kirsch R. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Hematol 1994;86:322-6.
32. Elsayed Y, Nakagawa K, Ichikawa K, Ohkawara S, Sueishi K. Expression of tissue factor and interleukin-1 beta in a novel rabbit model of disseminated intravascular coagulation induced by carrageenan and lipopolysaccharide. Pathobiology 1995;63:328-40.
33. Ono S, Mochizuki H, Tamakuma S. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery. Am J Surg 1996;171:409-15.
34. Ishibashi M, Ito N, Fujita M, Furue H, Yamaji T. Endothelin-1 as an aggravating factor for disseminated intravascular coagulation associated with malignant neoplams. Cancer 1994;73:191-5.
35. Okajima K, Fujise R, Motosato Y, Ushijima M, Okabe H, Takatsuki K. Plasma levels of granulocyte elastase alpha 1-proteinase inhibitor complex in patients with disseminated intravascular coagulation: pathophysiologic implications. Am J Hematol 1994;47:82-8.
36. Collins P, Noble K, Reittie J, Hoffbrand A, Pasi K, Yong K. Induction of tumour factor expression in human monocyte/endothelium cocultures. Br J Hematol 1995;91:963-70.
37. Mammen EF. Antithrombin: Its physiologic importance and role in DIC. Semin Thromb Hemostas 1998;24:19-25.
38. de Agostini AI, Watkins SC, Slayter HS, Youssoufian H, Rosenberg RD. Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: Antithrombin binding on cultured endothelial cells and perfused rat aorta. J Cell Biol 1990;111:1293-1304.
39. Yamanuchi T, Ume F, Inoguchi I, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989;163:1404-11.
40. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996;88:881-6.